Results 211 to 219 of about 142,846 (219)

Driving CAR T-cells forward

Nature Reviews Clinical Oncology, 2016
Renier J Brentjens, Sarwish Rafiq
exaly  

PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges

Biomedicine and Pharmacotherapy, 2020
Eileen M. McGowan, Yiguang Lin, Size Chen   +2 more
exaly  

In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes

Molecular Therapy, 2020
Christian J Buchholz, Shiwani Agarwal, Frederic Thalheimer   +2 more
exaly  

Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy

Cancers, 2016
Vita M Golubovskaya
exaly  

CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape

Molecular Therapy, 2018
James Smith, Zeeshaan Arshad, Georg A Holländer   +2 more
exaly  

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Molecular Therapy, 2018
Helen Heslop, Rayne H Rouce, Adrian P Gee   +2 more
exaly  

CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia

Molecular Therapy, 2019
Maksim Mamonkin, Feiyan Mo, Rayne H Rouce   +2 more
exaly  

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma

Cancer Cell
Roland T Ullrich, Hyatt Balke-Want
exaly  

CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines

Cell Reports Medicine
Thomas Look, Tobias Weiss
exaly